From secondsight.com

The recognized global leader in neuromodulation devices to treat blindness, the company leverages its 20 years of technology innovation to develop devices to treat the broadest population of sight-impaired individuals. Inspired by personal connections with a retinitis pigmentosa diagnosis, Second Sight has researched, designed and created the world’s first FDA and CE Mark approved device for providing artificial vision in people with late-stage RP.

The company is actively developing a cortical stimulation device that bypasses the diseased eye and has the potential to provide a new form of vision to individuals blinded due to a wide range of causes.

– See more at: http://www.secondsight.com